Medrad gains three-year supply pact from Consorta

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
Consorta Inc. has renewed a three-year agreement with Medrad Inc. as the exclusive supplier of vascular injection systems and related disposables for CT, MR and cardiovascular (CV) imaging.

Consorta is a cooperative of 12 Catholic healthcare systems with more than 400 acute care facilities and 1,800 other sites of care.

Medrad introduced the first-ever vascular injection systems used in CT, MR and cardiovascular imaging procedures.